Abstract:Purpose Von Hippel-Lindau (VHL) disease is a hereditary kidney cancer syndrome, with which patients are more likely to get affected by renal cell carcinoma (RCC), pancreatic cyst or tumor (PCT), central nervous system hemangioblastoma (CHB), retinal angiomas (RA), and pheochromocytoma (PHEO). Mutations of VHL gene located in 3p25 may impair the function of the VHL protein and lead to the disease. It's unclear why obvious phenotype varieties exist among VHL patients. Here we aimed to ascertain whether the mutation types and locations affect the phenotype. Methods We enrolled 577 Chinese VHL patients from 211 families and divided them into three groups and six subgroups according to their mutation types and locations. Cox survival analysis and Kaplan-Meier analysis were used to compare intergroup age-related tumor risks. Results Patients with nonsense or frameshift mutations that were located before residues 117 of VHL protein (NoF1 subgroup) hold lower age-related risks of VHL associated tumors (HR = 0.638, 95%CI 0.461-0.883, p = 0.007), CHB (HR = 0.596, 95%CI 0.409-0.868, p = 0.007) or PCT (HR = 0.595, 95%CI 0.368-0.961, p = 0.034) than patients whose mutations were located after residues 117 (NoF2 subgroup). Patients in NoF1 subgroup still had lower age-related risks of CHB (HR = 0.652, 95%CI 0.476-0.893, p = 0.008) and PCT (HR = 0.605, 95%CI 0.398-0.918, p = 0.018) compared with those in combined NoF2 subgroup and other truncating mutation patients. NoF1 subgroup correspondingly had a longer estimated median lifespan (64 vs. 55 year, p = 0.037) than NoF2 subgroup. Among patients with missense mutations of VHL, only a small minority (23 of 286 missense mutations carriers) carried mutations involving neither HIF-alpha binding region nor elongin C binding region, who were grouped in MO subgroup. MO subgroup seemed to have a higher age-related risk of PHEO. In the whole cohort (n = 577), PHEO was an independent protective factor for CHB (p = 0.001) and survival (p = 0.005). RA and CHB failed to predict the age-related risk of each other. Conclusion The mutation types and locations of VHL gene are associated with phenotypes. Genetic counselors could predict phenotypes more accurately based on more detailed genotype-phenotype correlations. Further genotype-phenotype studies should focus on the prediction of tumor recurrence, progression, and metastasis. The deep molecular mechanism of genotype-phenotype correlation is worth further exploring.

Mosaicism in von Hippel-Lindau disease with severe renal manifestations.

Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family

VHL mosaicism: the added value of multi-tissue analysis

A Clinical Analysis of Multilocular Cystic Renal Cell Carcinoma and Its Correlation with Mutation of the Von Hippel-Lindau Gene

De Novo VHL Germline Mutation Detected in a Patient with Mild Clinical Phenotype of Von Hippel-Lindau Disease.

p.N78S and p.R161Q germline mutations of the VHL gene are present in von Hippel-Lindau syndrome in two pedigrees.

Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.

The Genotype-Phenotype Association Of Von Hipple Lindau Disease Based On Mutation Locations: A Retrospective Study Of 577 Cases In A Chinese Population

Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype–phenotype correlation and gene therapy perspective

Family History of Von Hippel–Lindau Disease Was Uncommon in Chinese Patients: Suggesting the Higher Frequency of De Novo Mutations in VHL Gene in These Patients

Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel-Lindau Disease.

Unexpected Information Of Dna Deletions In Genome: Analysis Of One Vhl Case With Array-Cgh

Genotype-phenotype Correlations in Chinese Von Hippel-Lindau Disease Patients

Higher Prevalence of Novel Mutations in VHL Gene in Chinese Von Hippel-Lindau Disease Patients.

Von Hippel-Lindau Disease Type 2 in a Chinese Family with a VHL P.w88x Truncation

[Frequent Somatic Mutations of the Von Hippel-Lindau Tumor Suppressor Gene in Primary Sporadic Human Renal Clear Cell Carcinomas].

Identification of of a <i>PAX2</i> mutation from maternal mosaicism causes recurrent renal disorder in siblings

Preliminary Study of Whole-Genome Bisulfite Sequencing and Transcriptome Sequencing in VHL Disease-Associated Ccrcc.

Tumors in von Hippel-Lindau Syndrome: From Head to Toe-Comprehensive State-of-the-Art Review

Distinctive Clinicopathological Features of Von Hippel-Lindau-associated Hereditary Renal Cell Carcinoma: A Single-Institution Study

Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma